Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

FEED vs SNOA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SNOA Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

SNOA Overall Winner 6-Pillar Tally: FEED 0 – 5 SNOA (1 Tie) Matrix Metrics: FEED 2 – 8 SNOA

As of Nov 20, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) is the stronger overall head-to-head candidate over FEED (FEED) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FEED carries a Unified Composite Score of 37.1/100 (SELL) at $1.03 (N/M Forward P/E, N/A operating margin), whereas SNOA carries 36.4/100 (SELL) at $0.72 (46.1x Forward P/E, -3.3% operating margin).

  • Composite vs. Pillar Nuance: While FEED currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. SNOA 36.4/100 SELL), SNOA captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.3% vs. N/A operating margin) and revenue trajectory (+28.0% vs. N/A YoY).
  • Defensive Composite Rating Caution: Although SNOA compares more favorably head-to-head, both FEED (37.1/100 SELL) and SNOA (36.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: FEED trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 41.1); meanwhile SNOA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FEED vs SNOA
FEED US Equity
FEED
Institutional Equity
$1.03
-69.25% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -6.40β · 3942% Vol
Unified Composite Score
37.1 / 100 SELL
Tech 15.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.1 · SMA20: $1.98 · SMA50: $1.04
SNOA NASDAQ Head-to-Head Winner
Sonoma Pharmaceuticals, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.72
-10.83% 1D
Market Cap $4.1M
TTM Revenue $23M
Forward P/E 46.1x
Beta / 30D Vol 1.59β · 92% Vol
Unified Composite Score
36.4 / 100 SELL
Tech 25.0 Fund 37.0 Flow 50.0 Mom 34.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 24
RSI-14: 24.1 · SMA20: $1.05 · SMA50: $1.15

6-Pillar Scorecard Institutional Category Breakdown (FEED 0 – 5 SNOA)

Columns: Metric · FEED · SNOA
1. Valuation Multiples SNOA
Forward P/E N/M 46.1x
Trailing P/E N/M 46.1x
PEG Ratio N/M 1.08x
EV / Revenue N/M 0.1x
2. Growth & Scale SNOA
Revenue Growth (YoY) N/A +28.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $23M
Market Cap N/A $4.1M
3. Profitability & Quality SNOA
Gross Margin N/A 39.2%
Operating Margin N/A -3.3%
Net Profit Margin N/A -7.6%
Return on Equity (ROE) N/A -34.5%
4. Balance Sheet & Cash Flow SNOA
Cash Generation (TTM) N/A -$4.1M
Cash Flow Margin N/A -17.6%
Net Cash / Leverage N/A ROE $1.6M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat SNOA
OpEx & R&D Intensity N/A 42.5% of Rev ($10.0M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FEED (2) vs SNOA (8)
Institutional Metric FEED SNOA Criterion Row Edge
Market Capitalization
Scale
N/A $4.1M Larger Scale SNOA
Trailing P/E Ratio
Valuation
N/M 46.1x Lower Multiple SNOA
Forward P/E Ratio
Valuation
N/M 46.1x Lower Multiple SNOA
Revenue Growth (YoY)
Growth
N/A +28.0% Higher Growth SNOA
Operating Margin (TTM)
Profitability
N/A -3.3% Higher Margin SNOA
Net Profit Margin
Profitability
N/A -7.6% Higher Margin SNOA
Return on Equity (ROE)
Capital Efficiency
N/A -34.5% Higher ROE SNOA
52-Week Range Position
Momentum
13% ($0–$6) 0% ($1–$4) Stronger Trend FEED
Beta / 30D Volatility
Risk Regime
-6.40β · 3942% Vol 1.59β · 92% Vol Lower Realized Risk SNOA
Unified Institutional Score
Composite Signal
37.1 / 100 (SELL) 36.4 / 100 (SELL) Higher Composite FEED
Trailing 12M Revenue (USD)
Operating Scale
N/A $23M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 39.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.08x PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$4.1M ($1.6M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FEED +137.24 pp
FEED: +135.7% · SNOA: -1.54%
3M Horizon FEED +13.43 pp
FEED: +28.75% · SNOA: +15.32%
6M Horizon FEED +3.17 pp
FEED: -43.72% · SNOA: -46.89%
1Y Horizon SNOA +10.53 pp
FEED: -75.27% · SNOA: -64.74%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FEED vs SNOA. Trailing 12-month operating profitability (FEED N/A vs SNOA -3.3%) and valuation multiples (FEED N/M vs SNOA 46.1x Forward P/E) are benchmarked directly in Pillar 4 below.

FEED ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SNOA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$23M
Gross Margin39.2%
Op. Margin-3.3%
ROE / Fwd P/E-34.5% · 46.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FEED UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FEED Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SNOA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SNOA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FEED Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SNOA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $4.1M market capitalization and -3.3% operating margin.
OpEx & R&D Reinvestment 42.5% of Rev ($10.0M)
90D Engineering Disclosures 0 Published

Investor FAQ FEED vs SNOA Key Questions & Quantitative Answers

As of Nov 20, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) is the stronger overall head-to-head candidate over FEED (FEED) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FEED carries a Unified Composite Score of 37.1/100 (SELL) at $1.03 (N/M Forward P/E, N/A operating margin), whereas SNOA carries 36.4/100 (SELL) at $0.72 (46.1x Forward P/E, -3.3% operating margin). Composite vs. Pillar Nuance: While FEED currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. SNOA 36.4/100 SELL), SNOA captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.3% vs. N/A operating margin) and revenue trajectory (+28.0% vs. N/A YoY). Defensive Composite Rating Caution: Although SNOA compares more favorably head-to-head, both FEED (37.1/100 SELL) and SNOA (36.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: FEED trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 41.1); meanwhile SNOA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SNOA leads the Growth & Scale pillar: FEED posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SNOA at +28.0% YoY revenue growth and +0.0% YoY earnings growth on $23M TTM revenue (39.2% gross margin, -3.3% operating margin). On trailing 12-month operating scale, FEED generates N/A in USD-normalized revenue versus $23M for SNOA. In operating R&D and SG&A reinvestment, FEED deploys N/A (0 90-day corporate R&D disclosures) versus 42.5% of Rev ($10.0M) (0 disclosures) for SNOA.

SNOA screens cheaper on headline valuation multiples. FEED trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SNOA trades at 46.1x Forward P/E, 46.1x Trailing P/E, 1.08x PEG, and 0.1x EV/Revenue (-17.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FEED (N/A ROE) versus SNOA (-34.5% ROE) capital efficiency.

In options market volatility and institutional positioning, FEED carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-6.40β · 3942% Vol realized risk). By comparison, SNOA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.59β · 92% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.